Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 2552 results found. Search for [ COVID-19 research ]

Results 100 to 120 of 2552
BusinessToday.In
February 5, 2021
After Union Budget 2021, markets were enthused by the RBI Monetary Policy Committee (MPC) outcome of keeping the repo rate unchanged at 4% on February 5


PTI
February 5, 2021
The projection by the RBI governor is in line with the estimates in the Union Budget 2021-22 presented in Parliament earlier this week


PTI
February 5, 2021
The number of people who have recuperated from the disease surged to 1,04,96,308 pushing the national COVID-19 recovery rate to 97.16 percent, while the COVID-19 case fatality rate stands at 1.43 per cent


Joe C Mathew
New Delhi, February 5, 2021
The FM has set the stage, but timely execution is critical


PB Jayakumar
New Delhi, February 5, 2021
With record healthcare expenditure and allocations focussing on mitigating the impact of Covid-19, it's a shot in the arm for the sector


Rashi Bisaria
New Delhi, February 5, 2021
COVID-19 vaccination: Healthcare workers to receive second dose from Feb 13The second dose of anti-coronavirus vaccine will be administered to healthcare workers from February 13, the Centre said on Thursday, highlighting that 45 per cent of them have been inoculated so far. Addressing a press briefing, Union Health Secretary Rajesh Bhushan said 45,93,427 beneficiaries have been vaccinated against COVID-19 till 1.30 PM on Thursday.Over 21% Indians already exposed to COVID-19, shows sero-sur...


BusinessToday.In
February 5, 2021
India Stock Market News Updates Today: Sensex scaled record high of 51,073.27 while the Nifty hit record high of 15,014.65 level in early trade. SBI, Kotak Bank, IndusInd Bank, HDFC, ONGC and Axis Bank were top gainers in the Sensex pack


BusinessToday.In
February 4, 2021
ICMR conducted the third round of the national sero-survey from December 7, 2020, to January 8, 2021. The results of this survey have been released now


PTI
February 4, 2021
The yet-to-be peer-reviewed study, posted in the preprint repository medRxiv, assessed the antibody responses in 109 individuals with and without documented pre-existing immunity to the novel coronavirus


BusinessToday.In
February 4, 2021
The local unit opened at 72.92 against the US dollar at the interbank forex market and inched 6 paise higher to 72.90 over its previous close in early deals


BusinessToday.In
February 4, 2021
Dalal Street today: ITC, M&M, ONGC, Bajaj Finserv, NTPC were among the top gainers while ICICI Bank, IndusInd Bank, Infosys, HDFC traded as top losers


Reuters
February 4, 2021
The British researchers behind the trial said data on vaccinating people with the two different types of coronavirus vaccines could help understanding of whether shots can be rolled out with greater flexibility around the world


PTI
February 3, 2021
India Ratings and Research said only 5 per cent of its rated 450 issuers in the mid and emerging corporates (MEC) space had availed the RBI's financial restructuring facility available till December 31, 2020


Reuters
February 3, 2021
The state-run Indian Council of Medical Research (ICMR), which conducted the survey, said it would only share the findings at a news conference on Thursday. The source declined to be named ahead of the official announcement


BusinessToday.In
February 3, 2021
Meanwhile, Nifty Pharma index surged over 4% today. This was in line with Sensex and Nifty that hit fresh lifetime highs of 50,526 and 14,868 during today's session


BusinessToday.In
February 3, 2021
IndusInd Bank, followed by Dr Reddy's, PowerGrid, Tech Mahindra, M&M, Sun Pharma and Axis Bank were among the top gainers. On the other hand, Maruti, Kotak Bank, SBI and UltraTech Cement were among the losers


BusinessToday.In
February 3, 2021
Earlier, The Lancet had stated that Russia's experimental COVID-19 vaccine Sputnik V is 91.6 per cent affective against coronavirus infection. These results are based on Phase 3 trials of the vaccine in which 20,000 people had participated


Chitranjan Kumar
February 3, 2021
The report, however, revealed that there is a sense of professional uncertainty and worry among Indian professionals as the job market continues to get more competitive in 2021


PB Jayakumar
February 3, 2021
Bharat Biotech will supply initial doses to be used in the US upon Ocugen's receipt of an EUA from the US regulatory authorities


BusinessToday.In
February 3, 2021
The pharma stock touched an intraday high of Rs 4,759.1 rising 6.13% against previous close of Rs 4,484.25 on BSE


PAGES 6 OF 128  678910